186 related articles for article (PubMed ID: 27459300)
1. Expression of a Recombinant Anti-HIV and Anti-Tumor Protein, MAP30, in Nicotiana tobacum Hairy Roots: A pH-Stable and Thermophilic Antimicrobial Protein.
Moghadam A; Niazi A; Afsharifar A; Taghavi SM
PLoS One; 2016; 11(7):e0159653. PubMed ID: 27459300
[TBL] [Abstract][Full Text] [Related]
2. Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity.
Lv Q; Yang XZ; Fu LY; Lu YT; Lu YH; Zhao J; Wang FJ
Protein Expr Purif; 2015 Jul; 111():9-17. PubMed ID: 25797209
[TBL] [Abstract][Full Text] [Related]
3. Recombinant anti-HIV MAP30, a ribosome inactivating protein: against plant virus and bacteriophage.
Amirzadeh N; Moghadam A; Niazi A; Afsharifar A
Sci Rep; 2023 Feb; 13(1):2091. PubMed ID: 36747030
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity.
Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH
Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
Lee-Huang S; Huang PL; Chen HC; Huang PL; Bourinbaiar A; Huang HI; Kung HF
Gene; 1995 Aug; 161(2):151-6. PubMed ID: 7665070
[TBL] [Abstract][Full Text] [Related]
6. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
Meng Y; Liu S; Li J; Meng Y; Zhao X
Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682
[TBL] [Abstract][Full Text] [Related]
7. Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity.
Sun Y; Sun F; Li J; Wu M; Fan X; Meng Y; Meng Y
Molecules; 2016 Oct; 21(11):. PubMed ID: 27809255
[TBL] [Abstract][Full Text] [Related]
8. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
Fan X; He L; Meng Y; Li G; Li L; Meng Y
Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293
[TBL] [Abstract][Full Text] [Related]
9. A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L.
Meng Y; Lin S; Liu S; Fan X; Li G; Meng Y
PLoS One; 2014; 9(7):e101998. PubMed ID: 25003606
[TBL] [Abstract][Full Text] [Related]
10. [Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity].
Zhang LL; Ding Q; Zhan JB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):264-71. PubMed ID: 20544988
[TBL] [Abstract][Full Text] [Related]
11. Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII.
Arazi T; Lee Huang P; Huang PL; Zhang L; Moshe Shiboleth Y; Gal-On A; Lee-Huang S
Biochem Biophys Res Commun; 2002 Mar; 292(2):441-8. PubMed ID: 11906182
[TBL] [Abstract][Full Text] [Related]
12. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
13. Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells.
Hlin H; Zhi-Guo Z; Cong-Hui H; Yan Z; Qing L; Bo J; Hou-Guang H; Jun-Jie Z; Pei-Ying Z
Minerva Urol Nefrol; 2016 Jun; 68(3):275-81. PubMed ID: 25517785
[TBL] [Abstract][Full Text] [Related]
14. Ribosome-inactivating Protein MAP30 Isolated from
Zhou Y; Yang D; Qiang Z; Meng Y; Li R; Fan X; Zhao W; Meng Y
Recent Pat Anticancer Drug Discov; 2024; 19(2):223-232. PubMed ID: 36330636
[TBL] [Abstract][Full Text] [Related]
15. Zirconium phosphatidylcholine-based nanocapsules as an in vivo degradable drug delivery system of MAP30, a momordica anti-HIV protein.
Caizhen G; Yan G; Ronron C; Lirong Y; Panpan C; Xuemei H; Yuanbiao Q; Qingshan L
Int J Pharm; 2015 Apr; 483(1-2):188-99. PubMed ID: 25681721
[TBL] [Abstract][Full Text] [Related]
16. Recombinant production of bovine Lactoferrin-derived antimicrobial peptide in tobacco hairy roots expression system.
Chahardoli M; Fazeli A; Ghabooli M
Plant Physiol Biochem; 2018 Feb; 123():414-421. PubMed ID: 29310078
[TBL] [Abstract][Full Text] [Related]
17. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy.
Puri M; Kaur I; Kanwar RK; Gupta RC; Chauhan A; Kanwar JR
Curr Mol Med; 2009 Dec; 9(9):1080-94. PubMed ID: 19747115
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV and anti-tumor protein MAP30, a 30 kDa single-strand type-I RIP, shares similar secondary structure and beta-sheet topology with the A chain of ricin, a type-II RIP.
Wang YX; Jacob J; Wingfield PT; Palmer I; Stahl SJ; Kaufman JD; Huang PL; Huang PL; Lee-Huang S; Torchia DA
Protein Sci; 2000 Jan; 9(1):138-44. PubMed ID: 10739256
[TBL] [Abstract][Full Text] [Related]
19. Novel purification method and antibiotic activity of recombinant Momordica charantia MAP30.
Chang CD; Lin PY; Chen YC; Huang HH; Shih WL
3 Biotech; 2017 May; 7(1):3. PubMed ID: 28389897
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells.
Fan JM; Luo J; Xu J; Zhu S; Zhang Q; Gao DF; Xu YB; Zhang GP
Mol Biotechnol; 2008 May; 39(1):79-86. PubMed ID: 18246454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
